A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy.
Gist H FarrMelanie MorrisArianna GomezThao PhamElisabeth KilroyElizabeth U ParkerShery SaidClarissa HenryLisa MavesPublished in: Skeletal muscle (2020)
Our results provide novel, effective methods for performing a combination of small-molecule screen in zebrafish. Our results also add to the growing evidence that epigenetic small molecules may be promising candidates for treating DMD.